XTL BIOPHARMACEUTICALS LTD - XTLB
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GAMMA Investing LLC | History | Reduced | 3,388 | 8 | 0.0% | 0.0% | 1 | -9,499 | -73.71% | Q1 2026 | Apr 06, 2026 |
| Noked Israel Ltd | History | Closed out | 0 | 0 | — | 0.02% | — | -198,888 | -100.0% | Q4 2025 | Feb 13, 2026 |
| CITADEL ADVISORS LLC | History | Closed out | 0 | 0 | — | 0.0% | — | -75,866 | -100.0% | Q4 2025 | Feb 17, 2026 |
| RHUMBLINE ADVISERS | History | Closed out | 0 | 0 | — | 0.0% | — | -30,108 | -100.0% | Q4 2025 | Feb 13, 2026 |
| XTX Topco Ltd | History | Closed out | 0 | 0 | — | 0.0% | — | -10,238 | -100.0% | Q4 2025 | Feb 17, 2026 |
| MORGAN STANLEY | History | Closed out | 0 | 0 | — | 0.0% | — | -1,740 | -100.0% | Q4 2025 | Feb 13, 2026 |